Article(id=1256183395432915307, tenantId=1146029695717560320, journalId=1255847919539208197, issueId=1256183358493679805, articleNumber=null, orderNo=null, doi=10.13193/j.issn.1673-7717.2025.12.008, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1777427060229, onlineDateStr=2026-04-29, pubDate=1765296000000, pubDateStr=2025-12-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1777427060229, onlineIssueDateStr=2026-04-29, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1777427060229, creator=13701087609, updateTime=1777427060229, updator=13701087609, issue=Issue{id=1256183358493679805, tenantId=1146029695717560320, journalId=1255847919539208197, year='2025', volume='43', issue='12', pageStart='1', pageEnd='258', issueExtLink='null', onlineDate='null', pubDate='null', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=1, specialIssue=null, createTime=1777427051344, creator=13701087609, updateTime=1777427760067, updator=13701087609, preIssue=null, nextIssue=null, ext={EN=IssueExt(id=1256186331126969089, tenantId=1146029695717560320, journalId=1255847919539208197, issueId=1256183358493679805, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1256186331126969090, tenantId=1146029695717560320, journalId=1255847919539208197, issueId=1256183358493679805, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null}, startPage=47, endPage=54, ext={EN=ArticleExt(id=1256183402093470120, articleId=1256183395432915307, tenantId=1146029695717560320, journalId=1255847919539208197, language=EN, title=Investigating Effect of Sanqi(Notoginseng Radix et Rhizoma)on Mitochondrial Energy Metabolism in Rats with Renal Fibrosis Based on Metabolomics, columnId=1256183361521967297, journalTitle=Chinese Archives of Traditional Chinese Medicine, columnName=Target on National Project, runingTitle=null, highlight=null, articleAbstract=
Objective To study the effectof Sanqi(Notoginseng Radix et Rhizoma)onmitochondrial energy metabolism of rats with adriamycin induced kidney fibrosis with blood stasis.
Methods Thirty rats were divided into 6 groups random ly,including normal group,model group,Sanqi(Notoginseng Radix et Rhizoma)low-dose group,Sanqi(Notoginseng Radix et Rhizoma)medium-dose group,Sanqi(Notoginseng Radix et Rhizoma)high-dose group and positive control group,with 5 rats in each group.Themitochondrial structure of rat renal tissue was observed by electron microscopy.The contents of adenosine triphosphate(ATP),adenosine diphosphate(ADP),adenosine monophosphate(AMP),the activities of Na+ -K+ -ATPase,Ca2+ -Mg2+-ATPase and the activities ofmitochondrial respiratory chain complex enzymeⅠ-Ⅳwere detected by chemical method.The metabolites of urine were analyzed by liquid chromatograph and mass spectrometer.The differential metabolites were enriched by Kyoto Encyclopedia of Genes and Genomes(KEGG)metabolic pathway.
Results Under electron microscope,the mitochondrial structure of renal tissue in the model group was incomplete,and Sanqi(Notoginseng Radix et Rhizoma)could maintain the homeostasis of renalmitochondrial structure.Sanqi(Notoginseng Radix et Rhizoma)could increase the mitochondrial ATP contentof the renal tissue,the activities of Na+-K+-ATPase,Ca2+-Mg2+-ATPase andmitochondrial respiratory chain complex enzymeⅠ-Ⅳ.Sanqi(Notoginseng Radix et Rhizoma)could reduce the contents of mitochondrial ADP and AMP of renal tissue.After analysis and comparison among the groups,11 different urine metabolites were screened,including ferulic acid,forin,arabitol,acetamide,biotin,allantoic acid,6-methylmercaptopurine,4-hydroxy-2-quinolone,aminopentanedioate,6-methyladenine and moupinamide.Further enrichment of urinemetabolites by KEGG in different experimental groups showed that the aldosterone-regulated sodium reabsorption signal pathway was significantly different.
Conclusion Sanqi(Notoginseng Radix et Rhizoma)regulates the differential urine metabolites and raldosterone-regulated sodium reabsorption signal pathway.Sanqi(Notoginseng Radix et Rhizoma)can improve mitochondrial energy metabolism and renal fibrosis in chronic kidney diseases(CKD)rats with blood stasis bymulti-target and multi-pathway.
, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, authorCompany=null, fund=null, authors=null, authorsList=Zhimin HUANG, Liangxi LU, Jinyu WU), CN=ArticleExt(id=1256183549380649320, articleId=1256183395432915307, tenantId=1146029695717560320, journalId=1255847919539208197, language=CN, title=基于代谢组学探讨三七对肾纤维化大鼠线粒体能量代谢的影响, columnId=1256183362172142382, journalTitle=中华中医药学刊, columnName=国家项目点击, runingTitle=null, highlight=null, articleAbstract=
目的 研究三七对血瘀证阿霉素肾纤维化大鼠线粒体能量代谢的影响。
方法 将30只SD大鼠随机分为6组:正常组、模型组、三七低剂量组、三七中剂量组、三七高剂量组、阳性对照组,每组5只。采用电镜观察大鼠肾组织线粒体结构,化学法检测肾组织三磷酸腺苷(Adenosine triphosphate,ATP)、二磷酸腺苷(Adenosine diphosphate,ADP)、一磷酸腺苷(Adenosinemonophosphate,AMP)含量、Na+-K+-ATP酶、Ca2+-Mg2+-ATP酶活性、线粒体呼吸链复合体酶Ⅰ~Ⅳ活性。采用液相色谱仪、质谱仪对尿液进行代谢物成分分析,获得代谢差异物后,进行KEGG代谢通路富集。
结果 电镜下可见模型组大鼠肾组织线粒体结构不完整,三七可以维持肾组织线粒体结构稳态。三七可以提高肾组织线粒体ATP含量、Na+-K+-ATP酶、Ca2+-Mg2+-ATP酶、线粒体呼吸链复合体酶Ⅰ、Ⅱ、Ⅲ、Ⅳ活性;降低肾组织线粒体ADP、AMP含量。进行三七低、中、高剂量组、模型组和正常组分析对比,筛查出11个差异尿液代谢产物,分别为Ferulic acid、Morin、Arabitol、Acetamide、Biotin、Allantoic acid、6-Methylmercaptopurine、4-Hydroxy-2-quinolone、Aminopentanedioate、6-Methyladenine、Moupinamide。进一步对各实验组动物尿液代谢物KEGG通路富集分析结果显示:醛固酮调控的钠重吸收通路差异具有显著统计学意义。
结论 三七通过调节差异尿液代谢产物的代谢,调控醛固酮调节Na+重吸收通路,从多靶点、多途径改善血瘀证慢性肾脏疾病(Chronic Kidney Diseases,CKD)大鼠的线粒体能量代谢,发挥抗肾纤维化作用。
, correspAuthors=null, authorNote=null, correspAuthorsNote=
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=rmTp9dxJQCO1Nbk52ghMrA==, magXml=YEPfntjwHZtgA8Ql/vbSOg==, pdfUrl=null, pdf=YspK3HogOMuyNa+KuyTR6w==, pdfFileSize=6694706, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=etdBvOYz85hGFDTfTLn8+A==, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=8qVB8tvnwgtrPseO3cTzdg==, mapNumber=null, authorCompany=null, fund=null, authors=
黄志敏(1988-),女,广西贵港人,主治医师,博士,研究方向:中医药防治风湿免疫疾病。
, authorsList=黄志敏, 陆良喜, 吴金玉)}, authors=[Author(id=1256183557274329542, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1256183558536815066, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, authorId=1256183557274329542, language=EN, stringName=Zhimin HUANG, firstName=Zhimin, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.The First Affiliated Hospital of Guangxi University of Chinese Medicine,Guangxi Key Laboratory of Molecular Biology of Preventive Medicine of Traditional Chinese Medicine,Nanning 530023,Guangxi,China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1256183559388258791, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, authorId=1256183557274329542, language=CN, stringName=黄志敏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.广西中医药大学第一附属医院,广西中医药防治医学分子生物重点实验室,广西 南宁 530023, bio={"content":"
黄志敏(1988-),女,广西贵港人,主治医师,博士,研究方向:中医药防治风湿免疫疾病。
"}, bioImg=null, bioContent=
黄志敏(1988-),女,广西贵港人,主治医师,博士,研究方向:中医药防治风湿免疫疾病。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1256183554904547742, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, xref=1., ext=[AuthorCompanyExt(id=1256183555210731936, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, companyId=1256183554904547742, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.The First Affiliated Hospital of Guangxi University of Chinese Medicine,Guangxi Key Laboratory of Molecular Biology of Preventive Medicine of Traditional Chinese Medicine,Nanning 530023,Guangxi,China), AuthorCompanyExt(id=1256183555386892707, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, companyId=1256183554904547742, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.广西中医药大学第一附属医院,广西中医药防治医学分子生物重点实验室,广西 南宁 530023)])]), Author(id=1256183560776573431, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1256183562001310217, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, authorId=1256183560776573431, language=EN, stringName=Liangxi LU, firstName=Liangxi, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.Ren'ai Branch of The First Affiliated Hospital of Guangxi University of Chinese Medicine,Nanning 530001,Guangxi,China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1256183563590951445, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, authorId=1256183560776573431, language=CN, stringName=陆良喜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.广西中医药大学第一附属医院仁爱分院,广西 南宁 530001, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1256183556167033266, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, xref=2., ext=[AuthorCompanyExt(id=1256183556477411766, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, companyId=1256183556167033266, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Ren'ai Branch of The First Affiliated Hospital of Guangxi University of Chinese Medicine,Nanning 530001,Guangxi,China), AuthorCompanyExt(id=1256183556531937721, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, companyId=1256183556167033266, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.广西中医药大学第一附属医院仁爱分院,广西 南宁 530001)])]), Author(id=1256183565319004711, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wujinyu0109@sina.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1256183567344853558, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, authorId=1256183565319004711, language=EN, stringName=Jinyu WU, firstName=Jinyu, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.The First Affiliated Hospital of Guangxi University of Chinese Medicine,Guangxi Key Laboratory of Molecular Biology of Preventive Medicine of Traditional Chinese Medicine,Nanning 530023,Guangxi,China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1256183568208880191, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, authorId=1256183565319004711, language=CN, stringName=吴金玉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.广西中医药大学第一附属医院,广西中医药防治医学分子生物重点实验室,广西 南宁 530023, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1256183554904547742, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, xref=1., ext=[AuthorCompanyExt(id=1256183555210731936, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, companyId=1256183554904547742, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.The First Affiliated Hospital of Guangxi University of Chinese Medicine,Guangxi Key Laboratory of Molecular Biology of Preventive Medicine of Traditional Chinese Medicine,Nanning 530023,Guangxi,China), AuthorCompanyExt(id=1256183555386892707, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, companyId=1256183554904547742, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.广西中医药大学第一附属医院,广西中医药防治医学分子生物重点实验室,广西 南宁 530023)])])], keywords=[Keyword(id=1256183568762528328, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, orderNo=1, keyword=chronic kidney disease), Keyword(id=1256183569618166354, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, orderNo=2, keyword=Sanqi(Notoginseng Radix et Rhizoma)), Keyword(id=1256183570398306911, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, orderNo=3, keyword=renal fibrosis), Keyword(id=1256183571711124076, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, orderNo=4, keyword=mitochondrial energy metabolism), Keyword(id=1256183572805837435, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, orderNo=5, keyword=metabolomics), Keyword(id=1256183573644698243, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, orderNo=1, keyword=慢性肾脏病), Keyword(id=1256183574194152079, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, orderNo=2, keyword=三七), Keyword(id=1256183574923960986, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, orderNo=3, keyword=肾纤维化), Keyword(id=1256183575330808482, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, orderNo=4, keyword=线粒体能量代谢), Keyword(id=1256183575888650921, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, orderNo=5, keyword=代谢组学)], refs=[Reference(id=1256183590291891040, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2017, volume=2, issue=2, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=NEUEN B L, CHADBAN S J, DEMAIO A R, journalName=BMJGlob Health, refType=null, unstructuredReference=NEUEN B L,CHADBAN S J,DEMAIO A R,
et al. Chronic kidney disease and the global NCDs agenda[J].
BMJGlob Health,
2017,
2(2):e000380., articleTitle=Chronic kidney disease and the global NCDs agenda, refAbstract=null), Reference(id=1256183590539354977, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2020, volume=35, issue=10, pageStart=1801, pageEnd=1810, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=LI P K, GARCIA-GARCIA G, LUI S F, journalName=Pediatr Nephrol, refType=null, unstructuredReference=LI P K,GARCIA-GARCIA G,LUI S F,
et al. Kidney health for everyone everywhere-from prevention to detection and equitable access to care[J].
Pediatr Nephrol,
2020,
35(10):1801-1810., articleTitle=Kidney health for everyone everywhere-from prevention to detection and equitable access to care, refAbstract=null), Reference(id=1256183590803596130, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2023, volume=324, issue=6, pageStart=F571, pageEnd=F580, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=LUTHER T, BÜLOW-ANDERBERG S, PERSSON P, journalName=Am JPhysiol Renal Physiol, refType=null, unstructuredReference=LUTHER T,BÜLOW-ANDERBERG S,PERSSON P,
et al. Renal mitochondrial dysfunction in ovine experimental sepsis-associated acute kidney injury[J].
Am JPhysiol Renal Physiol,
2023,
324(6):F571-F580., articleTitle=Renal mitochondrial dysfunction in ovine experimental sepsis-associated acute kidney injury, refAbstract=null), Reference(id=1256183590975562595, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2019, volume=95, issue=6, pageStart=1389, pageEnd=1404, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=BAIM, CHEN H, DING D, journalName=Kidney Int, refType=null, unstructuredReference=BAIM,CHEN H,DING D,
et al. MicroRNA-214 promotes chronic kidney disease by disrupting mitochondrial oxidative phosphorylation[J].
Kidney Int,
2019,
95(6):1389-1404., articleTitle=MicroRNA-214 promotes chronic kidney disease by disrupting mitochondrial oxidative phosphorylation, refAbstract=null), Reference(id=1256183591072031588, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2019, volume=20, issue=5, pageStart=379, pageEnd=382, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=黄志敏, 黄仁发, 唐宇, journalName=中国中西医结合肾病杂志, refType=null, unstructuredReference=黄志敏,黄仁发,唐宇,
等. 基于JAK/STAT信号通路观察三七注射液对阿霉素诱导的肾纤维化大鼠炎症因子的影响[J].
中国中西医结合肾病杂志,
2019,
20(5):379-382., articleTitle=基于JAK/STAT信号通路观察三七注射液对阿霉素诱导的肾纤维化大鼠炎症因子的影响, refAbstract=null), Reference(id=1256183591155917669, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2021, volume=39, issue=9, pageStart=156, pageEnd=159, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=黄志敏, 黄仁发, 唐宇, journalName=中华中医药学刊, refType=null, unstructuredReference=黄志敏,黄仁发,唐宇,
等. 基于肠肾轴理论探讨三七注射液对慢性肾脏病大鼠肠黏膜功能和肠道菌群的影响[J].
中华中医药学刊,
2021,
39(9):156-159., articleTitle=基于肠肾轴理论探讨三七注射液对慢性肾脏病大鼠肠黏膜功能和肠道菌群的影响, refAbstract=null), Reference(id=1256183591319495526, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2021, volume=39, issue=5, pageStart=175, pageEnd=178, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=黄志敏, 黄仁发, 唐宇, journalName=中华中医药学刊, refType=null, unstructuredReference=黄志敏,黄仁发,唐宇,
等. 三七注射液对阿霉素肾纤维化大鼠炎症启动因子和终止因子的影响[J].
中华中医药学刊,
2021,
39(5):175-178., articleTitle=三七注射液对阿霉素肾纤维化大鼠炎症启动因子和终止因子的影响, refAbstract=null), Reference(id=1256183591390798695, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2010, volume=8, issue=2, pageStart=188, pageEnd=1903, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=赵玲, 魏海峰, 李雅莉, journalName=中西医结合心脑血管病杂志, refType=null, unstructuredReference=赵玲,魏海峰,李雅莉,
等. 从血液流变学的改变分析肾上腺素致血瘀证大鼠模型的建立[J].
中西医结合心脑血管病杂志,
2010,
8(2):188-1903., articleTitle=从血液流变学的改变分析肾上腺素致血瘀证大鼠模型的建立, refAbstract=null), Reference(id=1256183591474684776, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2020, volume=16, issue=9, pageStart=509, pageEnd=524, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=DWYER KM, KISHORE BK, ROBSON SC, journalName=Nat Rev Nephrol, refType=null, unstructuredReference=DWYER KM,KISHORE BK,ROBSON SC. Conversion of extracellular ATP into adenosine:amaster switch in renal health and disease[J].
Nat Rev Nephrol,
2020,
16(9):509-524., articleTitle=Conversion of extracellular ATP into adenosine:amaster switch in renal health and disease, refAbstract=null), Reference(id=1256183591608902505, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2017, volume=119, issue=4, pageStart=392, pageEnd=399, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=HUIY, LU M, HAN Y, el at, journalName=Acta Histochem, refType=null, unstructuredReference=HUIY,LU M,HAN Y,el at. Resveratrol improvesmitochondrial function in the remnant kidney from 5/6 nephrectomized rats[J].
Acta Histochem,
2017,
119(4):392-399., articleTitle=Resveratrol improvesmitochondrial function in the remnant kidney from 5/6 nephrectomized rats, refAbstract=null), Reference(id=1256183591734731626, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2019, volume=14, issue=12, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=AKHTAR S, SIRAGY H M, journalName=PLoSONE, refType=null, unstructuredReference=AKHTAR S,SIRAGY H M. Pro-renin receptor suppressesmitochondrial biogenesis and function via AMPK/SIRT-1/PGC-1alpha pathway in diabetic kidney[J].
PLoSONE,
2019,
14(12):e225728., articleTitle=Pro-renin receptor suppressesmitochondrial biogenesis and function via AMPK/SIRT-1/PGC-1alpha pathway in diabetic kidney, refAbstract=null), Reference(id=1256183591839589227, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2019, volume=4, issue=23, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=BHATIA D, CHUNG K P, NAKAHIRA K, journalName=JCI Insight, refType=null, unstructuredReference=BHATIA D,CHUNG K P,NAKAHIRA K,
et al. Mitophagy-dependentmacrophage reprogramming protects against kidney fibrosis[J].
JCI Insight,
2019,
4(23):e132826., articleTitle=Mitophagy-dependentmacrophage reprogramming protects against kidney fibrosis, refAbstract=null), Reference(id=1256183591923475308, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2020, volume=83, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=WANG D T, YANG Y J, ZOU X H, journalName=JNutr Biochem, refType=null, unstructuredReference=WANG D T,YANG Y J,ZOU X H,
et al. Curcumin ameliorates CKD-induced mitochondrial dysfunction and oxidative stress through inhibiting GSK-3βactivity[J].
JNutr Biochem,
2020,
83:108404., articleTitle=Curcumin ameliorates CKD-induced mitochondrial dysfunction and oxidative stress through inhibiting GSK-3βactivity, refAbstract=null), Reference(id=1256183592066081645, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2020, volume=13, issue=2, pageStart=176, pageEnd=178, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=杨倩春, 李思宁, 陈硕, journalName=临床合理用药杂志, refType=null, unstructuredReference=杨倩春,李思宁,陈硕,
等. 代谢组学的运用及其研究进展[J].
临床合理用药杂志,
2020,
13(2):176-178., articleTitle=代谢组学的运用及其研究进展, refAbstract=null), Reference(id=1256183592158356334, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2023, volume=16, issue=9, pageStart=1521, pageEnd=1533, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=BRILLAND B, BOUD'HORSC, WACRENIER S, journalName=Clin Kidney J, refType=null, unstructuredReference=BRILLAND B,BOUD'HORSC,WACRENIER S,
etal. Kidney injury molecule1(KIM-1):a potential biomarker of acute kidney injury and tubulointerstitial injury in patientswith ANCA-glomerulonephritis[J].
Clin Kidney J,
2023,
16(9):1521-1533., articleTitle=Kidney injury molecule1(KIM-1):a potential biomarker of acute kidney injury and tubulointerstitial injury in patientswith ANCA-glomerulonephritis, refAbstract=null), Reference(id=1256183592242242415, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2023, volume=24, issue=13, pageStart=10470, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=ROMEJKO K, MARKOWSKA M, NIEMCZYK S, journalName=Int JMol Sci, refType=null, unstructuredReference=ROMEJKO K,MARKOWSKA M,NIEMCZYK S. The review of current knowledge on neutrophil gelatinase-associated lipocalin(NGAL)[J].
Int JMol Sci,
2023,
24(13):10470., articleTitle=The review of current knowledge on neutrophil gelatinase-associated lipocalin(NGAL), refAbstract=null), Reference(id=1256183592330322800, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2022, volume=153, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=MA R Y, HE Y H, FANGQ, journalName=Biomed Pharmacother, refType=null, unstructuredReference=MA R Y,HE Y H,FANGQ,
etal. Ferulic acid ameliorates renal injury via improving autophagy to inhibit inflammation in diabetic nephropathymice[J].
Biomed Pharmacother,
2022,
153:113424., articleTitle=Ferulic acid ameliorates renal injury via improving autophagy to inhibit inflammation in diabetic nephropathymice, refAbstract=null), Reference(id=1256183592502289265, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2019, volume=9, issue=19, pageStart=32, pageEnd=35, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=陈璐, journalName=中国医药科学, refType=null, unstructuredReference=陈璐. 阿魏酸钠联合厄贝沙坦对慢性肾功能衰竭患者血清炎性因子、Hcy、PTH及β2-MG的影响[J].
中国医药科学,
2019,
9(19):32-35., articleTitle=阿魏酸钠联合厄贝沙坦对慢性肾功能衰竭患者血清炎性因子、Hcy、PTH及β2-MG的影响, refAbstract=null), Reference(id=1256183592569398130, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2018, volume=56, issue=null, pageStart=156, pageEnd=167, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=SINGH M P, CHAUHAN A K, KANG S C, journalName=Int Immunopharmacol, refType=null, unstructuredReference=SINGH M P,CHAUHAN A K,KANG S C. Morin hydrate ameliorates cisplatin-induced ER stress,inflammation and autophagy in HEK-293 cells and mice kidney via PARP-1 regulation[J].
Int Immunopharmacol,
2018,
56:156-167., articleTitle=Morin hydrate ameliorates cisplatin-induced ER stress,inflammation and autophagy in HEK-293 cells and mice kidney via PARP-1 regulation, refAbstract=null), Reference(id=1256183592636506995, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2021, volume=90, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=SINGH M P, SHARMA C, CHU S, journalName=Int Immuno-pharmacol, refType=null, unstructuredReference=SINGH M P,SHARMA C,CHU S. KANGMorin hydrate attenuates adenine-induced renal fibrosis via targeting cathepsin D signaling[J].
Int Immuno-pharmacol,
2021,
90:107234., articleTitle=KANGMorin hydrate attenuates adenine-induced renal fibrosis via targeting cathepsin D signaling, refAbstract=null), Reference(id=1256183592745558900, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2015, volume=30, issue=9, pageStart=1537, pageEnd=1540, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=VANLEDE K, KLUIJTMANS L A J, MONNENS L, journalName=Pediatr Nephrol, refType=null, unstructuredReference=VANLEDE K,KLUIJTMANS L A J,MONNENS L,
et al. Urinary excretion of polyols and sugars in children with chronic kidney disease[J].
Pediatr Nephrol,
2015,
30(9):1537-1540., articleTitle=Urinary excretion of polyols and sugars in children with chronic kidney disease, refAbstract=null), Reference(id=1256183592825250677, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2020, volume=2020, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=ZHANG H, ZUO JJ, DONG SS, journalName=Journal of diabetes research, refType=null, unstructuredReference=ZHANG H,ZUO JJ,DONG SS,
etal. Identification of potential serum metabolic biomarkers of diabetic kidney disease:a widely targeted metabolomics study[J].
Journal of diabetes research,
2020,
2020:3049098., articleTitle=Identification of potential serum metabolic biomarkers of diabetic kidney disease:a widely targeted metabolomics study, refAbstract=null), Reference(id=1256183592942691190, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2012, volume=53, issue=2, pageStart=117, pageEnd=124, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=SZMIT S, JANK M, MACIEJEWSKIH, journalName=Int Heart J, refType=null, unstructuredReference=SZMIT S,JANK M,MACIEJEWSKIH,
et al. White blood cell transcriptome correlates with renal function in acute heart failure[J].
Int Heart J,
2012,
53(2):117-124., articleTitle=White blood cell transcriptome correlates with renal function in acute heart failure, refAbstract=null), Reference(id=1256183593060131703, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2019, volume=1165, issue=null, pageStart=325, pageEnd=346, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=SHRESTHA A, CHE R, ZHANG A, journalName=Adv Exp Med Biol, refType=null, unstructuredReference=SHRESTHA A,CHE R,ZHANG A. Role of aldosterone in renal fibrosis[J].
Adv Exp Med Biol,
2019,
1165:325-346., articleTitle=Role of aldosterone in renal fibrosis, refAbstract=null), Reference(id=1256183593194349432, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2020, volume=21, issue=13, pageStart=4679, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=BALHORN R, HARTMANN C, SCHUPP N, journalName=Int JMol Sci, refType=null, unstructuredReference=BALHORN R,HARTMANN C,SCHUPP N. Aldosterone induces DNA damage and activation of Nrf2 mainly in tubuli ofmouse kidneys[J].
Int JMol Sci,
2020,
21(13):4679., articleTitle=Aldosterone induces DNA damage and activation of Nrf2 mainly in tubuli ofmouse kidneys, refAbstract=null), Reference(id=1256183593274041210, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2011, volume=178, issue=5, pageStart=2020, pageEnd=2031, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=ZHU C, HUANG S, YUAN Y, journalName=Am JPathol, refType=null, unstructuredReference=ZHU C,HUANG S,YUAN Y,
et al. Mitochondrial dysfunction mediates aldosterone-induced podocyte damage:a therapeutic target of PPARγ[J].
Am JPathol,
2011,
178(5):2020-2031., articleTitle=Mitochondrial dysfunction mediates aldosterone-induced podocyte damage:a therapeutic target of PPARγ, refAbstract=null), Reference(id=1256183593362121595, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, doi=null, pmid=null, pmcid=null, year=2020, volume=586, issue=7828, pageStart=287, pageEnd=291, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=HERNANSANZ-AGUSTÍN P, CHOYA-FOCES C, CARREGALROMERO S, journalName=Nature, refType=null, unstructuredReference=HERNANSANZ-AGUSTÍN P,CHOYA-FOCES C,CARREGALROMERO S,
et al. Na
+ controls hypoxic signalling by the mitochondrial respiratory chain[J].
Nature,
2020,
586(7828):287-291., articleTitle=Na
+ controls hypoxic signalling by the mitochondrial respiratory chain, refAbstract=null)], funds=[Fund(id=1256183589847294813, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, awardId=81960866, language=CN, fundingSource=国家自然科学基金地区科学基金项目(81960866), fundOrder=null, country=null), Fund(id=1256183590010872670, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, awardId=zyyzdxk-2023166, language=CN, fundingSource=国家中医药管理局高水平中医药重点学科建设项目-中医内科学(zyyzdxk-2023166), fundOrder=null, country=null), Fund(id=1256183590140896095, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, awardId=桂教科研〔2022〕1号, language=CN, fundingSource=中医学广西一流学科项目(桂教科研〔2022〕1号), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1256183554904547742, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, xref=1., ext=[AuthorCompanyExt(id=1256183555210731936, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, companyId=1256183554904547742, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.The First Affiliated Hospital of Guangxi University of Chinese Medicine,Guangxi Key Laboratory of Molecular Biology of Preventive Medicine of Traditional Chinese Medicine,Nanning 530023,Guangxi,China), AuthorCompanyExt(id=1256183555386892707, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, companyId=1256183554904547742, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.广西中医药大学第一附属医院,广西中医药防治医学分子生物重点实验室,广西 南宁 530023)]), AuthorCompany(id=1256183556167033266, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, xref=2., ext=[AuthorCompanyExt(id=1256183556477411766, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, companyId=1256183556167033266, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Ren'ai Branch of The First Affiliated Hospital of Guangxi University of Chinese Medicine,Nanning 530001,Guangxi,China), AuthorCompanyExt(id=1256183556531937721, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, companyId=1256183556167033266, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.广西中医药大学第一附属医院仁爱分院,广西 南宁 530001)])], figs=[ArticleFig(id=1256183576991752890, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=MxFdKN0kTfUa6L75zqio1w==, figureFileBig=etdBvOYz85hGFDTfTLn8+A==, tableContent=null), ArticleFig(id=1256183577457320645, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图1, caption=
透射电镜下观察各组大鼠肾脏中线粒体形态, figureFileSmall=MxFdKN0kTfUa6L75zqio1w==, figureFileBig=etdBvOYz85hGFDTfTLn8+A==, tableContent=null), ArticleFig(id=1256183578426204885, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=C5gV9pAx0CB3/0xwwdz1nA==, figureFileBig=ZCl+4sFOmQLZbQvyxwKWeQ==, tableContent=null), ArticleFig(id=1256183579126653662, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图2, caption=
各组慢性肾脏疾病大鼠样本正离子基峰图(BPC), figureFileSmall=C5gV9pAx0CB3/0xwwdz1nA==, figureFileBig=ZCl+4sFOmQLZbQvyxwKWeQ==, tableContent=null), ArticleFig(id=1256183579650941669, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=0ONJxTwJrfhDqixYTxsgGQ==, figureFileBig=r7psHOCKOtBl7a+CE0nFuw==, tableContent=null), ArticleFig(id=1256183580380750572, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图3, caption=
各组慢性肾脏疾病大鼠样本负离子基峰图(BPC), figureFileSmall=0ONJxTwJrfhDqixYTxsgGQ==, figureFileBig=r7psHOCKOtBl7a+CE0nFuw==, tableContent=null), ArticleFig(id=1256183580833735410, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=Qg1PvgzHtuobXvCq1vCzDQ==, figureFileBig=trQ6g0fdPHtPf8Cc9Fe81w==, tableContent=null), ArticleFig(id=1256183581102170872, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图4, caption=
各组慢性肾脏疾病大鼠尿液样本PCA得分图注:N_Con为正常组;Model为模型组;LD为三七低剂量组;MD为三七中剂量组;HD为三七高剂量组;P_Con为阳性对照组。
, figureFileSmall=Qg1PvgzHtuobXvCq1vCzDQ==, figureFileBig=trQ6g0fdPHtPf8Cc9Fe81w==, tableContent=null), ArticleFig(id=1256183581366412029, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=FfJphEUWDNj3+LgTWd0Qgw==, figureFileBig=8uX7Yzrm6Y9syVwdmFEq2w==, tableContent=null), ArticleFig(id=1256183581722927875, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图5, caption=
各组大鼠尿液样本负离子和正离子PLS-DA得分图注:N_Con为正常组;Model为模型组;LD为三七低剂量组;MD为三七中剂量组;HD为三七高剂量组;P_Con为阳性对照组。
, figureFileSmall=FfJphEUWDNj3+LgTWd0Qgw==, figureFileBig=8uX7Yzrm6Y9syVwdmFEq2w==, tableContent=null), ArticleFig(id=1256183582020723465, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=F8UWJiuoAPsXSBzfppBByg==, figureFileBig=uEER8uxlLw87DFD1zEqdWg==, tableContent=null), ArticleFig(id=1256183582192689933, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图6, caption=
各组慢性肾脏疾病大鼠比较差异代谢物火山图注:N_Con为正常组;Model为模型组;LD为三七低剂量组;MD为三七中剂量组;HD为三七高剂量组;P_Con为阳性对照组。
, figureFileSmall=F8UWJiuoAPsXSBzfppBByg==, figureFileBig=uEER8uxlLw87DFD1zEqdWg==, tableContent=null), ArticleFig(id=1256183582448542481, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=0V9c5vubSYYMpc+Yd69f1w==, figureFileBig=ETIfd9MCADBeRrnTuO/iaA==, tableContent=null), ArticleFig(id=1256183582591148820, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图7, caption=
各组慢性肾脏疾病大鼠差异代谢物注:N_Con为正常组;Model为模型组;LD为三七低剂量组;MD为三七中剂量组;HD为三七高剂量组。
, figureFileSmall=0V9c5vubSYYMpc+Yd69f1w==, figureFileBig=ETIfd9MCADBeRrnTuO/iaA==, tableContent=null), ArticleFig(id=1256183582700200727, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=vVIl6IZfSI7hR9SJaNj1Kw==, figureFileBig=tK7AmDQUwoEis8JLMz+tbQ==, tableContent=null), ArticleFig(id=1256183582909915931, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图8, caption=
三七各剂量组与模型组相比显著差异代谢物:3-Aminopentanedioate注:N_Con为正常组;Model为模型组;LD为三七低剂量组;MD为三七中剂量组;HD为三七高剂量组。
, figureFileSmall=vVIl6IZfSI7hR9SJaNj1Kw==, figureFileBig=tK7AmDQUwoEis8JLMz+tbQ==, tableContent=null), ArticleFig(id=1256183583048327966, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=e3XtQBBx1ltebuircN7yWA==, figureFileBig=j+RRZfyjpUai0cMPiB1bnQ==, tableContent=null), ArticleFig(id=1256183583304180512, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图9, caption=
三七各剂量组与模型组相比显著差异代谢物:4-Hydroxy-2-quinolone注:N_Con为正常组;Model为模型组;LD为三七低剂量组;MD为三七中剂量组;HD为三七高剂量组。
, figureFileSmall=e3XtQBBx1ltebuircN7yWA==, figureFileBig=j+RRZfyjpUai0cMPiB1bnQ==, tableContent=null), ArticleFig(id=1256183583866217250, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=iVDhGNuUZVBl1/PuqVnBDw==, figureFileBig=jicd86PIRc9hwxuuevT0pA==, tableContent=null), ArticleFig(id=1256183583941714725, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图10, caption=
三七各剂量组与模型组相比显著差异代谢物:6-Methyladenine注:N_Con为正常组;Model为模型组;LD为三七低剂量组;MD为三七中剂量组;HD为三七高剂量组。
, figureFileSmall=iVDhGNuUZVBl1/PuqVnBDw==, figureFileBig=jicd86PIRc9hwxuuevT0pA==, tableContent=null), ArticleFig(id=1256183584126264103, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=/6AcaEupy8gRq7eLs9F8WQ==, figureFileBig=x33ua729luusdKcbgd43sg==, tableContent=null), ArticleFig(id=1256183584247898920, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图11, caption=
三七各剂量组与模型组相比显著差异代谢物:6-Methylmercaptopurine注:N_Con为正常对照组;Model为模型组;LD为三七低剂量组;MD为三七中剂量组;HD为三七高剂量组。
, figureFileSmall=/6AcaEupy8gRq7eLs9F8WQ==, figureFileBig=x33ua729luusdKcbgd43sg==, tableContent=null), ArticleFig(id=1256183584528917291, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=+or7cnVRlaWuzn8jv8Twqw==, figureFileBig=rQIeIxqVrNDN3N0YRRSypw==, tableContent=null), ArticleFig(id=1256183584633774894, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图12, caption=
三七各剂量组与模型组相比显著差异代谢物:Allantoic acid注:N_Con为正常组;Model为模型组;LD为三七低剂量组;MD为三七中剂量组;HD为三七高剂量组。
, figureFileSmall=+or7cnVRlaWuzn8jv8Twqw==, figureFileBig=rQIeIxqVrNDN3N0YRRSypw==, tableContent=null), ArticleFig(id=1256183584969319217, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=h/JJ9ISwPQdP/EWqw6irqQ==, figureFileBig=ZLA25LCMQFAZVBUcRa3RLg==, tableContent=null), ArticleFig(id=1256183585061593908, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图13, caption=
三七各剂量组与模型组相比显著差异代谢物:Biotin注:N_Con为正常组;Model为模型组;LD为三七低剂量组;MD为三七中剂量组;HD为三七高剂量组。
, figureFileSmall=h/JJ9ISwPQdP/EWqw6irqQ==, figureFileBig=ZLA25LCMQFAZVBUcRa3RLg==, tableContent=null), ArticleFig(id=1256183585388749623, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=r4Nhbf0Z5TuXSuXvNdm45w==, figureFileBig=h+fpnjS8AglKohn8A9PTYA==, tableContent=null), ArticleFig(id=1256183585481024313, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图14, caption=
三七各剂量组与模型组相比显著差异代谢物:D-Arabitol注:N_Con为正常组;Model为模型组;LD为三七低剂量组;MD为三七中剂量组;HD为三七高剂量组。
, figureFileSmall=r4Nhbf0Z5TuXSuXvNdm45w==, figureFileBig=h+fpnjS8AglKohn8A9PTYA==, tableContent=null), ArticleFig(id=1256183585787208508, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=dUlO194KQK4Ur1FnVaXkTw==, figureFileBig=AiW1D0LSd5Cf+7ulwnSvUQ==, tableContent=null), ArticleFig(id=1256183586215027518, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图15, caption=
三七各剂量组与模型组相比显著差异代谢物:Morin注:N_Con为正常组;Model为模型组;LD为三七低剂量组;MD为三七中剂量组;HD为三七高剂量组。
, figureFileSmall=dUlO194KQK4Ur1FnVaXkTw==, figureFileBig=AiW1D0LSd5Cf+7ulwnSvUQ==, tableContent=null), ArticleFig(id=1256183586374411074, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=pATdzjmEHnyuywbVkKYd4g==, figureFileBig=sVUv/HdyAdPLvsRzfHnTJA==, tableContent=null), ArticleFig(id=1256183586739315522, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图16, caption=
三七各剂量组与模型组相比显著差异代谢物:Moupinamide注:N_Con为正常组;Model为模型组;LD为三七低剂量组;MD为三七中剂量组;HD为三七高剂量组。
, figureFileSmall=pATdzjmEHnyuywbVkKYd4g==, figureFileBig=sVUv/HdyAdPLvsRzfHnTJA==, tableContent=null), ArticleFig(id=1256183587112608582, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=2n0zn6UbqAJH+p4WXoo/IA==, figureFileBig=qsEikxtEXzRiGl74xlDOIQ==, tableContent=null), ArticleFig(id=1256183587251020616, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图17, caption=
三七各剂量组与模型组相比显著差异代谢物:trans-Ferulic acid注:N_Con为正常组;Model为模型组;LD为三七低剂量组;MD为三七中剂量组;HD为三七高剂量组。
, figureFileSmall=2n0zn6UbqAJH+p4WXoo/IA==, figureFileBig=qsEikxtEXzRiGl74xlDOIQ==, tableContent=null), ArticleFig(id=1256183587603342155, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=8slIEoWKiXoFiiULi/4fEw==, figureFileBig=CHqdnrCQDi0wKt8+3OnmOg==, tableContent=null), ArticleFig(id=1256183587964052301, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=图18, caption=
正常组、三七各剂量组与模型组相比差异代谢物通路分析结果注:每个点代表一个代谢通路,横坐标是富集到不同代谢通路中的Impact值,纵坐标是-log10(P)值,其中的P值是超几何分布检验的P值,P值越小,代表检测到的差异代谢物对该通路影响越显著。Impact值越大,圆点越大,该值可简单理解为贡献度,即该值越大,代表该通路下检测到的代谢物贡献度越高,对该代谢通路影响越大。颜色与P值相关,颜色越深,P值越小,颜色越浅,P值越大。
, figureFileSmall=8slIEoWKiXoFiiULi/4fEw==, figureFileBig=CHqdnrCQDi0wKt8+3OnmOg==, tableContent=null), ArticleFig(id=1256183588089881422, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=null, figureFileBig=null, tableContent=
| 组别 | n | ATP | ADP | AMP |
|---|
| 正常组 | 5 | 2.136±0.114 | 2.529±0.125 | 4.298(0.218) |
| 模型组 | 5 | 0.878±0.145a | 6.033±0.344a | 11.430(1.634)a |
| 三七低剂量组 | 5 | 1.015±0.095a | 4.835±0.296ab | 9.272(0.735)ab |
| 三七中剂量组 | 5 | 1.279±0.117ab | 4.435±0.272ab | 8.287(0.120)ab |
| 三七高剂量组 | 5 | 1.882±0.154ab | 2.889±0.253ab | 4.707(0.347)b |
| 阳性对照组 | 5 | 1.896±0.176ab | 3.411±0.243ab | 5.834(0.411)ab |
| F值/H值 | | 74.017 | 125.381 | 27.126 |
| P值 | | 0.000 | 0.000 | 0.000 |
), ArticleFig(id=1256183588379288401, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=表1, caption=
各组慢性肾脏疾病大鼠线粒体ATP、ADP、AMP含量比较分析
, figureFileSmall=null, figureFileBig=null, tableContent=
| 组别 | n | ATP | ADP | AMP |
|---|
| 正常组 | 5 | 2.136±0.114 | 2.529±0.125 | 4.298(0.218) |
| 模型组 | 5 | 0.878±0.145a | 6.033±0.344a | 11.430(1.634)a |
| 三七低剂量组 | 5 | 1.015±0.095a | 4.835±0.296ab | 9.272(0.735)ab |
| 三七中剂量组 | 5 | 1.279±0.117ab | 4.435±0.272ab | 8.287(0.120)ab |
| 三七高剂量组 | 5 | 1.882±0.154ab | 2.889±0.253ab | 4.707(0.347)b |
| 阳性对照组 | 5 | 1.896±0.176ab | 3.411±0.243ab | 5.834(0.411)ab |
| F值/H值 | | 74.017 | 125.381 | 27.126 |
| P值 | | 0.000 | 0.000 | 0.000 |
), ArticleFig(id=1256183588475757394, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=null, figureFileBig=null, tableContent=
| 组别 | n | Na+-K+-ATP酶活性 | Ca2+-Mg2+-ATP酶活性 |
|---|
| 正常组 | 5 | 5.838±0.281 | 3.314±0.092 |
| 模型组 | 5 | 2.561±0.133a | 1.261±0.106a |
| 三七低剂量组 | 5 | 3.132±0.175ab | 1.682±0.138ab |
| 三七中剂量组 | 5 | 3.722±0.188ab | 2.269±0.229ab |
| 三七高剂量组 | 5 | 4.771±0.275ab | 2.679±0.238ab |
| 阳性对照组 | 5 | 4.649±0.379ab | 2.762±0.240ab |
| F值 | | 113.655 | 82.937 |
| P值 | | 0.000 | 0.000 |
), ArticleFig(id=1256183588819690324, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=表2, caption=
各组慢性肾脏疾病大鼠线粒体ATP酶活性比较分析
, figureFileSmall=null, figureFileBig=null, tableContent=
| 组别 | n | Na+-K+-ATP酶活性 | Ca2+-Mg2+-ATP酶活性 |
|---|
| 正常组 | 5 | 5.838±0.281 | 3.314±0.092 |
| 模型组 | 5 | 2.561±0.133a | 1.261±0.106a |
| 三七低剂量组 | 5 | 3.132±0.175ab | 1.682±0.138ab |
| 三七中剂量组 | 5 | 3.722±0.188ab | 2.269±0.229ab |
| 三七高剂量组 | 5 | 4.771±0.275ab | 2.679±0.238ab |
| 阳性对照组 | 5 | 4.649±0.379ab | 2.762±0.240ab |
| F值 | | 113.655 | 82.937 |
| P值 | | 0.000 | 0.000 |
), ArticleFig(id=1256183588903576406, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=null, figureFileBig=null, tableContent=
| 组别 | n | Ⅰ | Ⅱ | Ⅲ | Ⅳ |
|---|
| 正常组 | 5 | 51.533±3.797 | 9.612(0.421) | 12.720±1.003 | 13.157(1.878) |
| 模型组 | 5 | 17.071±3.012a | 4.411(0.558)a | 3.902±0.233a | 5.205(1.234)a |
| 三七低剂量组 | 5 | 19.549±5.123a | 5.13(0.548)ab | 5.259±0.812ab | 5.239(1.582)a |
| 三七中剂量组 | 5 | 30.985±4.925ab | 5.47(0.459)ab | 7.311±1.015ab | 8.093(1.832)ab |
| 三七高剂量组 | 5 | 43.437±4.977ab | 7.896(3.096)b | 9.482±0.879ab | 10.702(1.811)ab |
| 阳性对照组 | 5 | 41.220±1.999ab | 7.425(3.649)b | 9.495±0.650ab | 9.640(0.287)ab |
| F值/χ2值 | | 55.647 | 22.492 | 78.314 | 26.079 |
| P值 | | 0.000 | 0.000 | 0.000 | 0.000 |
), ArticleFig(id=1256183589151040344, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=表3, caption=
各组慢性肾脏疾病大鼠肾组织线粒体呼吸链复合体酶活性比较
, figureFileSmall=null, figureFileBig=null, tableContent=
| 组别 | n | Ⅰ | Ⅱ | Ⅲ | Ⅳ |
|---|
| 正常组 | 5 | 51.533±3.797 | 9.612(0.421) | 12.720±1.003 | 13.157(1.878) |
| 模型组 | 5 | 17.071±3.012a | 4.411(0.558)a | 3.902±0.233a | 5.205(1.234)a |
| 三七低剂量组 | 5 | 19.549±5.123a | 5.13(0.548)ab | 5.259±0.812ab | 5.239(1.582)a |
| 三七中剂量组 | 5 | 30.985±4.925ab | 5.47(0.459)ab | 7.311±1.015ab | 8.093(1.832)ab |
| 三七高剂量组 | 5 | 43.437±4.977ab | 7.896(3.096)b | 9.482±0.879ab | 10.702(1.811)ab |
| 阳性对照组 | 5 | 41.220±1.999ab | 7.425(3.649)b | 9.495±0.650ab | 9.640(0.287)ab |
| F值/χ2值 | | 55.647 | 22.492 | 78.314 | 26.079 |
| P值 | | 0.000 | 0.000 | 0.000 | 0.000 |
), ArticleFig(id=1256183589285258074, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=EN, label=null, caption=null, figureFileSmall=null, figureFileBig=null, tableContent=
| 名称 | mz | rt | P .value | VIP | Model | LD | MD | HD |
|---|
| N-Methyl-2-pyrrolidinone | 100.075 9 | 350.6 | 0.019 3 | 1.049 8 | no change | no change | no change | no change |
| 1-Aminocyclopropanecarboxylic acid | 102.055 2 | 159.4 | 0.000 0 | 1.353 8 | down | no change | up | no change |
| 2-Phenylethanol | 105.069 6 | 381.9 | 0.024 2 | 2.164 8 | no change | no change | no change | up |
| Imidazole-4-acetaldehyde | 111.055 1 | 121.1 | 0.012 0 | 2.388 3 | up | no change | no change | up |
| Histamine | 112.086 7 | 74.6 | 0.011 7 | 1.105 4 | no change | no change | up | no change |
| Purine | 120.044 2 | 694.3 | 0.006 1 | 2.348 1 | up | up | no change | no change |
| Maltol | 127.038 5 | 231.2 | 0.000 0 | 1.467 1 | no change | up | no change | no change |
| (S)-2,3,4,5-tetrahydropyridine-2-carboxylate | 128.070 3 | 341.5 | 0.000 7 | 1.234 4 | no change | no change | no change | no change |
| 5-Hydroxymethylfurfuryl alcohol | 128.049 4 | 673.7 | 0.034 4 | 2.835 0 | no change | down | down | down |
| Octanal | 129.127 2 | 596.8 | 0.005 2 | 1.128 8 | down | no change | no change | no change |
| 5-Amino-2-oxopentanoic acid | 131.070 0 | 199.0 | 0.027 2 | 2.152 7 | no change | no change | no change | down |
| N-Acetyl-beta-alanine | 132.065 0 | 162.3 | 0.047 5 | 1.792 8 | up | up | no change | no change |
| 1,3-Dihydro-(2H)-indol-2-one | 134.059 9 | 452.4 | 0.002 3 | 1.407 2 | no change | up | up | no change |
| Phosphonoacetate | 140.070 4 | 299.7 | 0.034 9 | 2.038 5 | up | no change | no change | up |
| Valpromide | 144.137 9 | 474.4 | 0.018 8 | 2.297 4 | no change | up | no change | no change |
| Acetylcholine | 146.117 2 | 96.7 | 0.023 4 | 1.598 0 | up | up | no change | up |
| O-Acetylserine | 148.060 1 | 159.2 | 0.030 2 | 1.583 3 | no change | down | no change | no change |
| Cuminaldehyde | 149.095 8 | 488.1 | 0.012 0 | 1.704 1 | down | down | no change | down |
| D-Arabitol | 152.070 3 | 432.7 | 0.000 2 | 1.720 7 | down | no change | down | down |
| Protocatechuic acid | 155.106 4 | 537.4 | 0.013 6 | 1.700 3 | no change | down | no change | no change |
| Tranexamic Acid | 158.117 3 | 414.6 | 0.004 5 | 1.910 3 | down | no change | down | down |
| D-Alanyl-D-alanine | 160.096 6 | 442.1 | 0.008 5 | 1.166 0 | up | no change | up | up |
| 4-Hydroxy-2-quinolone | 161.046 8 | 476.7 | 0.003 1 | 1.887 7 | up | up | no change | no change |
| N-methyl-L-glutamic Acid | 161.070 7 | 502.1 | 0.032 2 | 1.247 6 | up | no change | no change | no change |
| Anabasine | 163.038 7 | 591.9 | 0.004 1 | 1.874 3 | no change | down | no change | no change |
| Isosafrole | 163.075 2 | 868.4 | 0.003 4 | 1.661 0 | up | up | up | up |
| Enol-phenylpyruvate | 165.054 3 | 310.7 | 0.003 0 | 1.845 7 | up | no change | up | up |
| 4-Phenylbutyrate | 165.090 6 | 545.7 | 0.001 8 | 1.166 5 | no change | up | no change | no change |
| Epinephrine | 166.086 2 | 377.7 | 0.000 2 | 1.499 5 | no c hange | up | up | up |
| Desaminotyrosine | 167.073 9 | 164.6 | 0.032 3 | 1.352 5 | up | up | up | no change |
| Tropate | 167.081 3 | 425.3 | 0.001 7 | 1.504 5 | no change | up | up | no change |
| Perillic acid | 167.106 1 | 617.9 | 0.002 2 | 1.505 2 | no change | no change | down | no change |
| Quinolinic acid | 167.012 6 | 74.7 | 0.003 0 | 1.479 4 | no change | no change | no change | no change |
| Isopyridoxal | 168.065 1 | 197.4 | 0.046 2 | 1.597 0 | no change | no change | up | no change |
| Pyridoxamine | 169.097 1 | 269.8 | 0.013 9 | 1.421 1 | no change | no change | no change | no change |
| 2-Biphenylol | 171.076 4 | 298.5 | 0.001 3 | 1.137 9 | down | no change | down | down |
| Iminoarginine | 172.107 8 | 210.5 | 0.045 4 | 1.333 9 | no change | no change | up | no change |
| Swainsonine | 174.112 1 | 350.0 | 0.019 2 | 1.444 0 | down | no change | no change | no change |
| Formiminoglutamic acid | 175.071 0 | 101.7 | 0.023 0 | 1.512 9 | no change | no change | no change | no change |
| 1 H-Indole-3-acetamide | 175.086 4 | 503.2 | 0.043 1 | 1.929 3 | down | no change | no change | down |
| 3-Methyl-L-tyrosine | 178.086 1 | 325.5 | 0.006 0 | 2.552 8 | no change | no change | no change | up |
| Methyleugenolu | 179.106 4 | 792.0 | 0.002 0 | 1.352 7 | up | no change | no change | up |
| 5-Oxo-1,2-campholide | 183.101 2 | 612.8 | 0.012 3 | 1.165 2 | up | up | no change | no change |
| Sebacic acid | 185.117 5 | 528.6 | 0.042 7 | 2.034 5 | up | no change | no change | up |
| Deethylatrazine | 188.070 3 | 673.5 | 0.022 0 | 2.026 3 | up | up | up | up |
| Methyl(indol-3-yl)acetate | 189.078 3 | 649.5 | 0.024 6 | 2.096 0 | no change | no change | no change | up |
| Myristicin | 193.085 4 | 515.9 | 0.002 3 | 2.131 1 | up | no change | no change | up |
| Methoxamine | 194.117 4 | 217.6 | 0.025 6 | 2.140 0 | down | no change | no change | down |
| 3,4-Methylenedioxyamphetamine | 194.117 0 | 313.1 | 0.002 1 | 2.791 8 | no change | no change | no change | down |
| (-)-Bornesitol | 194.081 0 | 512.0 | 0.001 6 | 1.231 4 | up | up | up | no change |
| Dopaquinone | 196.059 9 | 375.3 | 0.043 0 | 1.788 0 | no change | down | down | down |
| Dethiobiotin | 197.127 9 | 209.0 | 0.000 3 | 1.345 3 | up | up | up | up |
| N-Acetylhistidine | 198.086 6 | 100.4 | 0.033 5 | 1.392 9 | down | no change | no change | no change |
| Spermine | 203.222 5 | 77.4 | 0.002 9 | 1.089 6 | no change | no change | no change | no change |
| Bufotenin | 205.137 2 | 177.1 | 0.015 4 | 1.260 8 | no change | down | no change | no change |
| trans-Isoasarone | 209.116 8 | 490.0 | 0.014 2 | 1.417 9 | no change | up | no change | no change |
| Propoxur | 210.112 3 | 467.3 | 0.005 9 | 2.200 1 | up | up | up | up |
| (+)-7-Isojasmonic acid | 211.132 4 | 481.2 | 0.000 1 | 1.072 9 | up | up | up | up |
| 3-Methyl-1-(2,4,6-trihydroxyphenyl)-1-butanone | 211.096 0 | 515.9 | 0.031 2 | 2.018 0 | no change | no change | no change | up |
| Apiole | 223.095 4 | 570.2 | 0.005 7 | 1.875 3 | up | up | up | no change |
| Terbutaline | 226.143 1 | 651.6 | 0.007 8 | 2.487 9 | no change | down | down | down |
| Pirbuterol | 241.153 9 | 128.0 | 0.000 1 | 1.774 1 | up | no change | up | no change |
| Ribavirin | 244.078 6 | 96.9 | 0.003 4 | 1.272 0 | up | no change | no change | down |
| Biotin | 245.094 9 | 461.3 | 0.001 7 | 1.297 4 | down | no change | no change | no change |
| Osthol | 245.116 5 | 716.3 | 0.000 1 | 1.671 2 | up | no change | up | no change |
| N-Acetyl-D-tryptophan | 247.128 3 | 377.2 | 0.015 3 | 2.368 8 | no change | no change | no change | up |
| D-Octopine | 247.139 1 | 96.8 | 0.004 1 | 2.145 9 | up | no change | no change | up |
| 5-Hydroxyindoleacetylglycine | 249.086 4 | 515.1 | 0.016 6 | 2.172 1 | no change | no change | up | up |
| Citrinin | 251.090 7 | 605.2 | 0.000 4 | 1.329 6 | up | no change | up | up |
| 16-Oxopalmitate | 253.215 4 | 705.9 | 0.002 3 | 1.894 7 | no change | down | no change | no change |
| 16-Hydroxy hexadecanoic acid | 255.230 8 | 844.2 | 0.036 8 | 1.898 8 | no change | no change | no change | no change |
| Stearolic acid | 263.236 2 | 868.1 | 0.000 8 | 2.952 8 | down | down | down | down |
| gamma-Glutamyltyramine | 266.120 7 | 454.9 | 0.000 0 | 1.732 3 | up | up | up | up |
| Nevirapine | 267.120 0 | 488.9 | 0.001 2 | 1.761 9 | no change | up | up | up |
| Xanthoxic acid | 267.162 8 | 667.4 | 0.043 1 | 1.620 8 | no change | no change | no change | no change |
| Baicalein | 271.179 7 | 702.9 | 0.000 0 | 1.909 4 | no change | no change | up | no change |
| (5-L-Glutamyl)-L-glutamate | 277.103 7 | 131.7 | 0.000 1 | 1.341 7 | up | up | up | up |
| Sulfamethazine | 279.092 6 | 749.0 | 0.040 8 | 1.030 1 | no change | no change | no change | no change |
| Guanosine | 284.098 4 | 280.3 | 0.034 0 | 1.141 6 | no change | no change | no change | no change |
| 9-OxoODE | 295.225 6 | 867.6 | 0.008 8 | 2.429 9 | up | up | no change | up |
| Enterolactone | 299.126 8 | 594.6 | 0.002 1 | 1.547 7 | up | no change | up | up |
| Dihydrocapsaicin | 308.220 7 | 626.3 | 0.000 1 | 2.735 5 | up | up | up | up |
| Moupinamide | 314.123 7 | 174.4 | 0.019 1 | 1.143 0 | down | no change | no change | no change |
| N-Acetylthienamycin | 314.102 6 | 76.8 | 0.038 8 | 1.170 4 | no change | no change | down | no change |
| Oxycodone | 316.154 1 | 510.0 | 0.027 2 | 1.497 7 | up | up | up | no change |
| Clostebol | 323.182 7 | 653.5 | 0.004 4 | 1.738 5 | no cha nge | no change | up | no change |
| Melibiose | 325.112 6 | 322.2 | 0.015 2 | 2.389 3 | no cha nge | no change | no change | no change |
| Bitertanol | 338.194 7 | 732.1 | 0.001 0 | 2.094 7 | no change | down | no change | no change |
| 17alpha,21-Dihydroxypregnenolone | 349.235 9 | 563.2 | 0.012 0 | 1.706 2 | no change | no change | no change | no change |
| Cortisone | 360.202 7 | 450.8 | 0.004 1 | 1.179 6 | up | up | up | no change |
| Aldosterone | 361.220 4 | 877.6 | 0.035 6 | 1.759 6 | no change | no change | no change | no change |
| 18-Hydroxycorticosterone | 363.214 7 | 546.5 | 0.023 3 | 1.170 0 | no change | no change | no change | down |
| Tangeritin | 373.127 5 | 794.1 | 0.000 0 | 1.097 4 | down | no change | down | down |
| S-Adenosylmethionine | 398.239 8 | 792.9 | 0.016 6 | 1.347 2 | no change | no change | no change | no change |
| N1,N8-Bis(4-coumaroyl)spermidine | 438.240 2 | 489.8 | 0.003 8 | 1.191 6 | down | no change | no change | down |
| Creatinine | 112.984 7 | 921.7 | 0.011 9 | 2.422 1 | no change | no change | no change | up |
| 5-Aminopentanoic acid | 115.920 9 | 813.7 | 0.017 1 | 1.614 0 | no change | no change | down | down |
| Citramalic acid | 129.018 8 | 142.0 | 0.001 0 | 1.893 8 | down | no change | down | down |
| Glycyl-glycine | 132.048 9 | 177.9 | 0.034 7 | 1.877 3 | no change | no change | no change | down |
| Adenine | 134.047 4 | 250.6 | 0.034 4 | 1.943 5 | no change | no change | no change | no change |
| 3-Dehydro-L-threonate | 134.024 9 | 452.7 | 0.001 3 | 1.297 0 | down | no change | down | down |
| Threonic acid | 135.030 1 | 118.1 | 0.043 1 | 1.451 5 | no change | no change | no change | no change |
| Dimethylbenzimidazole | 145.040 8 | 431.2 | 0.005 8 | 2.076 3 | no change | no change | no change | no change |
| D-Glutamine | 145.062 2 | 88.5 | 0.017 8 | 1.212 3 | no change | no change | no change | no change |
| 3-Aminopentanedioate | 146.046 0 | 94.3 | 0.000 9 | 1.252 4 | up | no change | no change | no change |
| 6-Methyladenine | 148.063 0 | 350.2 | 0.009 5 | 1.673 5 | up | no change | no change | up |
| D-Xylose | 149.045 7 | 93.0 | 0.015 5 | 1.286 7 | up | no change | no change | up |
| (R)-Mandelamide | 151.060 6 | 983.4 | 0.011 8 | 1.356 9 | no change | down | no change | no change |
| 3-Hydroxyvalproic acid | 159.102 6 | 331.4 | 0.030 8 | 1.513 1 | no change | no change | no change | no change |
| Oxoadipic acid | 160.040 6 | 454.3 | 0.022 4 | 2.288 4 | no change | no change | no change | up |
| Umbelliferone | 161.024 5 | 533.1 | 0.048 6 | 2.446 7 | no change | no change | no change | no change |
| L-Phenylalanine | 164.071 8 | 304.9 | 0.008 4 | 1.220 6 | no change | no change | no change | up |
| 6-Methylmercaptopurine | 165.021 0 | 142.5 | 0.001 0 | 1.642 3 | up | up | no change | no change |
| Terephthalate | 165.019 7 | 388.4 | 0.022 1 | 1.642 2 | no change | no change | no change | up |
| Hydantoin-5-propionic acid | 171.041 4 | 95.7 | 0.018 2 | 1.498 5 | up | no change | no change | no change |
| N-Acetylleucine | 172.098 0 | 340.4 | 0.017 4 | 1.108 7 | no change | no change | no change | up |
| Allantoic acid | 175.048 3 | 82.7 | 0.000 1 | 1.035 9 | down | no change | no change | no change |
| 2-Dehydro-D-glucono-1,5-lactone | 176.035 3 | 206.6 | 0.001 2 | 1.209 1 | no change | down | no change | no change |
| D-Mannonate | 177.040 5 | 81.4 | 0.002 7 | 1.195 3 | no change | down | no change | no change |
| 4-Hydroxyphenylpyruvic acid | 179.035 2 | 303.3 | 0.000 4 | 1.048 9 | no change | no change | no change | no change |
| D-Mannose | 179.056 4 | 90.1 | 0.012 9 | 1.120 3 | no change | no change | up | no change |
| Homovanillate | 181.050 7 | 164.0 | 0.021 2 | 2.061 9 | up | up | no change | no change |
| Hydroxyphenyllactic acid | 181.050 5 | 253.8 | 0.000 0 | 2.968 4 | no change | up | up | up |
| 2',6'-Dihydroxy-4'-methoxyacetophenone | 181.050 6 | 426.9 | 0.033 6 | 1.037 9 | up | no change | up | no change |
| 10-Oxodecanoate | 186.121 9 | 459.7 | 0.003 8 | 1.003 1 | no change | down | no change | no change |
| trans-Ferulic acid | 193.050 8 | 296.6 | 0.000 1 | 1.614 6 | down | down | down | down |
| Galactaric acid | 209.030 2 | 77.5 | 0.001 7 | 1.450 4 | up | no change | no change | no change |
| Milrinone | 210.067 1 | 609.4 | 0.004 5 | 1.762 7 | no change | no change | no change | no change |
| Tridecanoic acid | 214.108 6 | 393.8 | 0.050 0 | 2.001 8 | no change | no change | no change | down |
| N-Acetyl-D-glucosamine | 221.154 8 | 855.3 | 0.010 5 | 1.773 0 | no change | no change | no change | no change |
| Aciclovir | 225.080 3 | 425.4 | 0.006 0 | 1.062 3 | down | no change | down | down |
| Xylitol 5-phosphate | 231.027 7 | 100.4 | 0.024 8 | 1.257 3 | up | no change | up | no change |
| Equol | 241.087 2 | 685.9 | 0.003 2 | 1.631 0 | no change | down | no change | no change |
| Uridine | 243.061 8 | 166.7 | 0.019 9 | 2.366 6 | down | down | no change | no change |
| Pyridoxal phosphate | 247.028 0 | 317.9 | 0.011 7 | 1.148 0 | up | no change | no change | no change |
| Shikimate 3-phosphate | 253.017 8 | 470.8 | 0.003 9 | 2.324 5 | no change | no change | no change | down |
| Palmitic acid | 255.233 1 | 874.8 | 0.002 3 | 1.503 0 | up | no change | no change | no change |
| Zidovudine | 267.090 7 | 459.3 | 0.000 0 | 1.243 5 | up | up | up | up |
| Norizalpinin | 269.045 6 | 471.3 | 0.013 3 | 1.542 7 | no change | no change | down | no change |
| 3'-Hydroxydaidzein | 269.045 5 | 537.3 | 0.011 1 | 1.040 4 | no change | no change | no change | no change |
| Arbutin | 272.095 7 | 569.0 | 0.004 3 | 2.042 9 | down | no change | no change | down |
| beta-D-3-Ribofuranosyluric acid | 281.053 9 | 128.2 | 0.021 9 | 1.251 5 | no change | no change | no change | no change |
| Dihydrotestosterone | 289.165 9 | 322.0 | 0.000 0 | 1.042 4 | up | no change | up | up |
| Kaempferide | 299.056 3 | 687.9 | 0.000 1 | 1.744 2 | up | n o change | no change | no change |
| Morin | 301.037 7 | 369.6 | 0.036 2 | 1.052 9 | down | no change | no change | no change |
| (S,E)-Zearalenone | 317.139 2 | 787.7 | 0.001 7 | 2.381 2 | no change | no change | no change | no change |
| GMP | 344.039 7 | 149.6 | 0.001 8 | 1.044 0 | no change | up | no change | down |
| Pirenzepine | 350.163 4 | 521.1 | 0.000 0 | 1.605 7 | up | no change | up | down |
| Sinigrin | 359.033 7 | 419.2 | 0.000 0 | 2.481 8 | no change | up | no change | up |
| Deoxycholic acid | 392.288 1 | 790.8 | 0.019 7 | 1.005 2 | no change | no change | no change | no change |
| Carvedilol | 405.189 0 | 563.4 | 0.021 2 | 1.369 0 | down | down | no change | no change |
| Allocholic acid | 407.281 7 | 677.7 | 0.031 1 | 1.169 0 | down | down | down | no change |
| Daidzin | 415.101 5 | 491.3 | 0.040 8 | 1.823 3 | no change | no change | no change | no change |
| Astragalin | 448.108 5 | 464.7 | 0.028 8 | 2.674 4 | no ch ange | no change | no change | no change |
), ArticleFig(id=1256183589583053660, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1256183395432915307, language=CN, label=表4, caption=
差异代谢物
, figureFileSmall=null, figureFileBig=null, tableContent=
| 名称 | mz | rt | P .value | VIP | Model | LD | MD | HD |
|---|
| N-Methyl-2-pyrrolidinone | 100.075 9 | 350.6 | 0.019 3 | 1.049 8 | no change | no change | no change | no change |
| 1-Aminocyclopropanecarboxylic acid | 102.055 2 | 159.4 | 0.000 0 | 1.353 8 | down | no change | up | no change |
| 2-Phenylethanol | 105.069 6 | 381.9 | 0.024 2 | 2.164 8 | no change | no change | no change | up |
| Imidazole-4-acetaldehyde | 111.055 1 | 121.1 | 0.012 0 | 2.388 3 | up | no change | no change | up |
| Histamine | 112.086 7 | 74.6 | 0.011 7 | 1.105 4 | no change | no change | up | no change |
| Purine | 120.044 2 | 694.3 | 0.006 1 | 2.348 1 | up | up | no change | no change |
| Maltol | 127.038 5 | 231.2 | 0.000 0 | 1.467 1 | no change | up | no change | no change |
| (S)-2,3,4,5-tetrahydropyridine-2-carboxylate | 128.070 3 | 341.5 | 0.000 7 | 1.234 4 | no change | no change | no change | no change |
| 5-Hydroxymethylfurfuryl alcohol | 128.049 4 | 673.7 | 0.034 4 | 2.835 0 | no change | down | down | down |
| Octanal | 129.127 2 | 596.8 | 0.005 2 | 1.128 8 | down | no change | no change | no change |
| 5-Amino-2-oxopentanoic acid | 131.070 0 | 199.0 | 0.027 2 | 2.152 7 | no change | no change | no change | down |
| N-Acetyl-beta-alanine | 132.065 0 | 162.3 | 0.047 5 | 1.792 8 | up | up | no change | no change |
| 1,3-Dihydro-(2H)-indol-2-one | 134.059 9 | 452.4 | 0.002 3 | 1.407 2 | no change | up | up | no change |
| Phosphonoacetate | 140.070 4 | 299.7 | 0.034 9 | 2.038 5 | up | no change | no change | up |
| Valpromide | 144.137 9 | 474.4 | 0.018 8 | 2.297 4 | no change | up | no change | no change |
| Acetylcholine | 146.117 2 | 96.7 | 0.023 4 | 1.598 0 | up | up | no change | up |
| O-Acetylserine | 148.060 1 | 159.2 | 0.030 2 | 1.583 3 | no change | down | no change | no change |
| Cuminaldehyde | 149.095 8 | 488.1 | 0.012 0 | 1.704 1 | down | down | no change | down |
| D-Arabitol | 152.070 3 | 432.7 | 0.000 2 | 1.720 7 | down | no change | down | down |
| Protocatechuic acid | 155.106 4 | 537.4 | 0.013 6 | 1.700 3 | no change | down | no change | no change |
| Tranexamic Acid | 158.117 3 | 414.6 | 0.004 5 | 1.910 3 | down | no change | down | down |
| D-Alanyl-D-alanine | 160.096 6 | 442.1 | 0.008 5 | 1.166 0 | up | no change | up | up |
| 4-Hydroxy-2-quinolone | 161.046 8 | 476.7 | 0.003 1 | 1.887 7 | up | up | no change | no change |
| N-methyl-L-glutamic Acid | 161.070 7 | 502.1 | 0.032 2 | 1.247 6 | up | no change | no change | no change |
| Anabasine | 163.038 7 | 591.9 | 0.004 1 | 1.874 3 | no change | down | no change | no change |
| Isosafrole | 163.075 2 | 868.4 | 0.003 4 | 1.661 0 | up | up | up | up |
| Enol-phenylpyruvate | 165.054 3 | 310.7 | 0.003 0 | 1.845 7 | up | no change | up | up |
| 4-Phenylbutyrate | 165.090 6 | 545.7 | 0.001 8 | 1.166 5 | no change | up | no change | no change |
| Epinephrine | 166.086 2 | 377.7 | 0.000 2 | 1.499 5 | no c hange | up | up | up |
| Desaminotyrosine | 167.073 9 | 164.6 | 0.032 3 | 1.352 5 | up | up | up | no change |
| Tropate | 167.081 3 | 425.3 | 0.001 7 | 1.504 5 | no change | up | up | no change |
| Perillic acid | 167.106 1 | 617.9 | 0.002 2 | 1.505 2 | no change | no change | down | no change |
| Quinolinic acid | 167.012 6 | 74.7 | 0.003 0 | 1.479 4 | no change | no change | no change | no change |
| Isopyridoxal | 168.065 1 | 197.4 | 0.046 2 | 1.597 0 | no change | no change | up | no change |
| Pyridoxamine | 169.097 1 | 269.8 | 0.013 9 | 1.421 1 | no change | no change | no change | no change |
| 2-Biphenylol | 171.076 4 | 298.5 | 0.001 3 | 1.137 9 | down | no change | down | down |
| Iminoarginine | 172.107 8 | 210.5 | 0.045 4 | 1.333 9 | no change | no change | up | no change |
| Swainsonine | 174.112 1 | 350.0 | 0.019 2 | 1.444 0 | down | no change | no change | no change |
| Formiminoglutamic acid | 175.071 0 | 101.7 | 0.023 0 | 1.512 9 | no change | no change | no change | no change |
| 1 H-Indole-3-acetamide | 175.086 4 | 503.2 | 0.043 1 | 1.929 3 | down | no change | no change | down |
| 3-Methyl-L-tyrosine | 178.086 1 | 325.5 | 0.006 0 | 2.552 8 | no change | no change | no change | up |
| Methyleugenolu | 179.106 4 | 792.0 | 0.002 0 | 1.352 7 | up | no change | no change | up |
| 5-Oxo-1,2-campholide | 183.101 2 | 612.8 | 0.012 3 | 1.165 2 | up | up | no change | no change |
| Sebacic acid | 185.117 5 | 528.6 | 0.042 7 | 2.034 5 | up | no change | no change | up |
| Deethylatrazine | 188.070 3 | 673.5 | 0.022 0 | 2.026 3 | up | up | up | up |
| Methyl(indol-3-yl)acetate | 189.078 3 | 649.5 | 0.024 6 | 2.096 0 | no change | no change | no change | up |
| Myristicin | 193.085 4 | 515.9 | 0.002 3 | 2.131 1 | up | no change | no change | up |
| Methoxamine | 194.117 4 | 217.6 | 0.025 6 | 2.140 0 | down | no change | no change | down |
| 3,4-Methylenedioxyamphetamine | 194.117 0 | 313.1 | 0.002 1 | 2.791 8 | no change | no change | no change | down |
| (-)-Bornesitol | 194.081 0 | 512.0 | 0.001 6 | 1.231 4 | up | up | up | no change |
| Dopaquinone | 196.059 9 | 375.3 | 0.043 0 | 1.788 0 | no change | down | down | down |
| Dethiobiotin | 197.127 9 | 209.0 | 0.000 3 | 1.345 3 | up | up | up | up |
| N-Acetylhistidine | 198.086 6 | 100.4 | 0.033 5 | 1.392 9 | down | no change | no change | no change |
| Spermine | 203.222 5 | 77.4 | 0.002 9 | 1.089 6 | no change | no change | no change | no change |
| Bufotenin | 205.137 2 | 177.1 | 0.015 4 | 1.260 8 | no change | down | no change | no change |
| trans-Isoasarone | 209.116 8 | 490.0 | 0.014 2 | 1.417 9 | no change | up | no change | no change |
| Propoxur | 210.112 3 | 467.3 | 0.005 9 | 2.200 1 | up | up | up | up |
| (+)-7-Isojasmonic acid | 211.132 4 | 481.2 | 0.000 1 | 1.072 9 | up | up | up | up |
| 3-Methyl-1-(2,4,6-trihydroxyphenyl)-1-butanone | 211.096 0 | 515.9 | 0.031 2 | 2.018 0 | no change | no change | no change | up |
| Apiole | 223.095 4 | 570.2 | 0.005 7 | 1.875 3 | up | up | up | no change |
| Terbutaline | 226.143 1 | 651.6 | 0.007 8 | 2.487 9 | no change | down | down | down |
| Pirbuterol | 241.153 9 | 128.0 | 0.000 1 | 1.774 1 | up | no change | up | no change |
| Ribavirin | 244.078 6 | 96.9 | 0.003 4 | 1.272 0 | up | no change | no change | down |
| Biotin | 245.094 9 | 461.3 | 0.001 7 | 1.297 4 | down | no change | no change | no change |
| Osthol | 245.116 5 | 716.3 | 0.000 1 | 1.671 2 | up | no change | up | no change |
| N-Acetyl-D-tryptophan | 247.128 3 | 377.2 | 0.015 3 | 2.368 8 | no change | no change | no change | up |
| D-Octopine | 247.139 1 | 96.8 | 0.004 1 | 2.145 9 | up | no change | no change | up |
| 5-Hydroxyindoleacetylglycine | 249.086 4 | 515.1 | 0.016 6 | 2.172 1 | no change | no change | up | up |
| Citrinin | 251.090 7 | 605.2 | 0.000 4 | 1.329 6 | up | no change | up | up |
| 16-Oxopalmitate | 253.215 4 | 705.9 | 0.002 3 | 1.894 7 | no change | down | no change | no change |
| 16-Hydroxy hexadecanoic acid | 255.230 8 | 844.2 | 0.036 8 | 1.898 8 | no change | no change | no change | no change |
| Stearolic acid | 263.236 2 | 868.1 | 0.000 8 | 2.952 8 | down | down | down | down |
| gamma-Glutamyltyramine | 266.120 7 | 454.9 | 0.000 0 | 1.732 3 | up | up | up | up |
| Nevirapine | 267.120 0 | 488.9 | 0.001 2 | 1.761 9 | no change | up | up | up |
| Xanthoxic acid | 267.162 8 | 667.4 | 0.043 1 | 1.620 8 | no change | no change | no change | no change |
| Baicalein | 271.179 7 | 702.9 | 0.000 0 | 1.909 4 | no change | no change | up | no change |
| (5-L-Glutamyl)-L-glutamate | 277.103 7 | 131.7 | 0.000 1 | 1.341 7 | up | up | up | up |
| Sulfamethazine | 279.092 6 | 749.0 | 0.040 8 | 1.030 1 | no change | no change | no change | no change |
| Guanosine | 284.098 4 | 280.3 | 0.034 0 | 1.141 6 | no change | no change | no change | no change |
| 9-OxoODE | 295.225 6 | 867.6 | 0.008 8 | 2.429 9 | up | up | no change | up |
| Enterolactone | 299.126 8 | 594.6 | 0.002 1 | 1.547 7 | up | no change | up | up |
| Dihydrocapsaicin | 308.220 7 | 626.3 | 0.000 1 | 2.735 5 | up | up | up | up |
| Moupinamide | 314.123 7 | 174.4 | 0.019 1 | 1.143 0 | down | no change | no change | no change |
| N-Acetylthienamycin | 314.102 6 | 76.8 | 0.038 8 | 1.170 4 | no change | no change | down | no change |
| Oxycodone | 316.154 1 | 510.0 | 0.027 2 | 1.497 7 | up | up | up | no change |
| Clostebol | 323.182 7 | 653.5 | 0.004 4 | 1.738 5 | no cha nge | no change | up | no change |
| Melibiose | 325.112 6 | 322.2 | 0.015 2 | 2.389 3 | no cha nge | no change | no change | no change |
| Bitertanol | 338.194 7 | 732.1 | 0.001 0 | 2.094 7 | no change | down | no change | no change |
| 17alpha,21-Dihydroxypregnenolone | 349.235 9 | 563.2 | 0.012 0 | 1.706 2 | no change | no change | no change | no change |
| Cortisone | 360.202 7 | 450.8 | 0.004 1 | 1.179 6 | up | up | up | no change |
| Aldosterone | 361.220 4 | 877.6 | 0.035 6 | 1.759 6 | no change | no change | no change | no change |
| 18-Hydroxycorticosterone | 363.214 7 | 546.5 | 0.023 3 | 1.170 0 | no change | no change | no change | down |
| Tangeritin | 373.127 5 | 794.1 | 0.000 0 | 1.097 4 | down | no change | down | down |
| S-Adenosylmethionine | 398.239 8 | 792.9 | 0.016 6 | 1.347 2 | no change | no change | no change | no change |
| N1,N8-Bis(4-coumaroyl)spermidine | 438.240 2 | 489.8 | 0.003 8 | 1.191 6 | down | no change | no change | down |
| Creatinine | 112.984 7 | 921.7 | 0.011 9 | 2.422 1 | no change | no change | no change | up |
| 5-Aminopentanoic acid | 115.920 9 | 813.7 | 0.017 1 | 1.614 0 | no change | no change | down | down |
| Citramalic acid | 129.018 8 | 142.0 | 0.001 0 | 1.893 8 | down | no change | down | down |
| Glycyl-glycine | 132.048 9 | 177.9 | 0.034 7 | 1.877 3 | no change | no change | no change | down |
| Adenine | 134.047 4 | 250.6 | 0.034 4 | 1.943 5 | no change | no change | no change | no change |
| 3-Dehydro-L-threonate | 134.024 9 | 452.7 | 0.001 3 | 1.297 0 | down | no change | down | down |
| Threonic acid | 135.030 1 | 118.1 | 0.043 1 | 1.451 5 | no change | no change | no change | no change |
| Dimethylbenzimidazole | 145.040 8 | 431.2 | 0.005 8 | 2.076 3 | no change | no change | no change | no change |
| D-Glutamine | 145.062 2 | 88.5 | 0.017 8 | 1.212 3 | no change | no change | no change | no change |
| 3-Aminopentanedioate | 146.046 0 | 94.3 | 0.000 9 | 1.252 4 | up | no change | no change | no change |
| 6-Methyladenine | 148.063 0 | 350.2 | 0.009 5 | 1.673 5 | up | no change | no change | up |
| D-Xylose | 149.045 7 | 93.0 | 0.015 5 | 1.286 7 | up | no change | no change | up |
| (R)-Mandelamide | 151.060 6 | 983.4 | 0.011 8 | 1.356 9 | no change | down | no change | no change |
| 3-Hydroxyvalproic acid | 159.102 6 | 331.4 | 0.030 8 | 1.513 1 | no change | no change | no change | no change |
| Oxoadipic acid | 160.040 6 | 454.3 | 0.022 4 | 2.288 4 | no change | no change | no change | up |
| Umbelliferone | 161.024 5 | 533.1 | 0.048 6 | 2.446 7 | no change | no change | no change | no change |
| L-Phenylalanine | 164.071 8 | 304.9 | 0.008 4 | 1.220 6 | no change | no change | no change | up |
| 6-Methylmercaptopurine | 165.021 0 | 142.5 | 0.001 0 | 1.642 3 | up | up | no change | no change |
| Terephthalate | 165.019 7 | 388.4 | 0.022 1 | 1.642 2 | no change | no change | no change | up |
| Hydantoin-5-propionic acid | 171.041 4 | 95.7 | 0.018 2 | 1.498 5 | up | no change | no change | no change |
| N-Acetylleucine | 172.098 0 | 340.4 | 0.017 4 | 1.108 7 | no change | no change | no change | up |
| Allantoic acid | 175.048 3 | 82.7 | 0.000 1 | 1.035 9 | down | no change | no change | no change |
| 2-Dehydro-D-glucono-1,5-lactone | 176.035 3 | 206.6 | 0.001 2 | 1.209 1 | no change | down | no change | no change |
| D-Mannonate | 177.040 5 | 81.4 | 0.002 7 | 1.195 3 | no change | down | no change | no change |
| 4-Hydroxyphenylpyruvic acid | 179.035 2 | 303.3 | 0.000 4 | 1.048 9 | no change | no change | no change | no change |
| D-Mannose | 179.056 4 | 90.1 | 0.012 9 | 1.120 3 | no change | no change | up | no change |
| Homovanillate | 181.050 7 | 164.0 | 0.021 2 | 2.061 9 | up | up | no change | no change |
| Hydroxyphenyllactic acid | 181.050 5 | 253.8 | 0.000 0 | 2.968 4 | no change | up | up | up |
| 2',6'-Dihydroxy-4'-methoxyacetophenone | 181.050 6 | 426.9 | 0.033 6 | 1.037 9 | up | no change | up | no change |
| 10-Oxodecanoate | 186.121 9 | 459.7 | 0.003 8 | 1.003 1 | no change | down | no change | no change |
| trans-Ferulic acid | 193.050 8 | 296.6 | 0.000 1 | 1.614 6 | down | down | down | down |
| Galactaric acid | 209.030 2 | 77.5 | 0.001 7 | 1.450 4 | up | no change | no change | no change |
| Milrinone | 210.067 1 | 609.4 | 0.004 5 | 1.762 7 | no change | no change | no change | no change |
| Tridecanoic acid | 214.108 6 | 393.8 | 0.050 0 | 2.001 8 | no change | no change | no change | down |
| N-Acetyl-D-glucosamine | 221.154 8 | 855.3 | 0.010 5 | 1.773 0 | no change | no change | no change | no change |
| Aciclovir | 225.080 3 | 425.4 | 0.006 0 | 1.062 3 | down | no change | down | down |
| Xylitol 5-phosphate | 231.027 7 | 100.4 | 0.024 8 | 1.257 3 | up | no change | up | no change |
| Equol | 241.087 2 | 685.9 | 0.003 2 | 1.631 0 | no change | down | no change | no change |
| Uridine | 243.061 8 | 166.7 | 0.019 9 | 2.366 6 | down | down | no change | no change |
| Pyridoxal phosphate | 247.028 0 | 317.9 | 0.011 7 | 1.148 0 | up | no change | no change | no change |
| Shikimate 3-phosphate | 253.017 8 | 470.8 | 0.003 9 | 2.324 5 | no change | no change | no change | down |
| Palmitic acid | 255.233 1 | 874.8 | 0.002 3 | 1.503 0 | up | no change | no change | no change |
| Zidovudine | 267.090 7 | 459.3 | 0.000 0 | 1.243 5 | up | up | up | up |
| Norizalpinin | 269.045 6 | 471.3 | 0.013 3 | 1.542 7 | no change | no change | down | no change |
| 3'-Hydroxydaidzein | 269.045 5 | 537.3 | 0.011 1 | 1.040 4 | no change | no change | no change | no change |
| Arbutin | 272.095 7 | 569.0 | 0.004 3 | 2.042 9 | down | no change | no change | down |
| beta-D-3-Ribofuranosyluric acid | 281.053 9 | 128.2 | 0.021 9 | 1.251 5 | no change | no change | no change | no change |
| Dihydrotestosterone | 289.165 9 | 322.0 | 0.000 0 | 1.042 4 | up | no change | up | up |
| Kaempferide | 299.056 3 | 687.9 | 0.000 1 | 1.744 2 | up | n o change | no change | no change |
| Morin | 301.037 7 | 369.6 | 0.036 2 | 1.052 9 | down | no change | no change | no change |
| (S,E)-Zearalenone | 317.139 2 | 787.7 | 0.001 7 | 2.381 2 | no change | no change | no change | no change |
| GMP | 344.039 7 | 149.6 | 0.001 8 | 1.044 0 | no change | up | no change | down |
| Pirenzepine | 350.163 4 | 521.1 | 0.000 0 | 1.605 7 | up | no change | up | down |
| Sinigrin | 359.033 7 | 419.2 | 0.000 0 | 2.481 8 | no change | up | no change | up |
| Deoxycholic acid | 392.288 1 | 790.8 | 0.019 7 | 1.005 2 | no change | no change | no change | no change |
| Carvedilol | 405.189 0 | 563.4 | 0.021 2 | 1.369 0 | down | down | no change | no change |
| Allocholic acid | 407.281 7 | 677.7 | 0.031 1 | 1.169 0 | down | down | down | no change |
| Daidzin | 415.101 5 | 491.3 | 0.040 8 | 1.823 3 | no change | no change | no change | no change |
| Astragalin | 448.108 5 | 464.7 | 0.028 8 | 2.674 4 | no ch ange | no change | no change | no change |
)], attaches=null, journal=Journal(id=1255846881855815682, delFlag=0, nameCn=中华中医药学刊, nameEn=Chinese Archives of Traditional Chinese Medicine, nameHistory1=null, nameHistory2=null, issn=1673-7717, eissn=null, cn=21-1546/R, coden=null, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=v4T+dd+NLAnioIpGAbkcEQ==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Archives of Traditional Chinese Medicine, journalRemark=null, publicationField=null, createdTime=1777346829146, updatedTime=1777347949387, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=C, firstLetterEn=C, subjectCode=Life Sciences, subjectName=null, subjectCodeEn=Life Sciences, subjectNameEn=null, picCn=v4T+dd+NLAnioIpGAbkcEQ==, picEn=RAy5vuC40hwJB+Y0pEARug==, jcr=null, cjcr=null, exts=[JournalExt(id=1255851580587368789, language=CN, name=中华中医药学刊, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1777347949406, updatedTime=1777347949406, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zyhs.cbpt.cnki.net/index.aspx?t=1, submissionEditorUrl=https://zyhs.cbpt.cnki.net/index.aspx?t=3, submissionReviewUrl=https://zyhs.cbpt.cnki.net/index.aspx?t=2, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1255851580641894742, language=EN, name=Chinese Archives of Traditional Chinese Medicine, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1777347949419, updatedTime=1777347949419, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zyhs.cbpt.cnki.net/index.aspx?t=1, submissionEditorUrl=https://zyhs.cbpt.cnki.net/index.aspx?t=3, submissionReviewUrl=https://zyhs.cbpt.cnki.net/index.aspx?t=2, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1255847919539208197, websiteList=[Website(id=1255847989868900719, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1255847919539208197, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zhzyyxk/CN, language=CN, createTime=1777347093312, createBy=18614031015, updateTime=1777347427646, updateBy=18614031015, name=中华中医药学刊-中文, tplId=1146099689490845704, title=中华中医药学刊, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1255849512594170105, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989868900719, code=articleTextType, value=kx, createTime=1777347456358, updateTime=1777347456358, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849512564809974, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989868900719, code=banner, value=null, createTime=1777347456352, updateTime=1777347456352, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849512631918844, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989868900719, code=grayFlag, value=0, createTime=1777347456367, updateTime=1777347456367, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849512552227061, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989868900719, code=logo, value=https://castjournals.cast.org.cn/joweb/zhzyyxk/CN/file/pic?fileId=uitCA2DBwhJaQSiSV07uhw==, createTime=1777347456348, updateTime=1777347456348, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849512657084670, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989868900719, code=minRunFlag, value=0, createTime=1777347456373, updateTime=1777347456373, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849512589975800, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989868900719, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zhzyyxk/CN/file/pic, createTime=1777347456357, updateTime=1777347456357, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849512648696061, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989868900719, code=silenceFlag, value=0, createTime=1777347456371, updateTime=1777347456371, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849512581587191, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989868900719, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1777347456355, updateTime=1777347456355, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849512619335930, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989868900719, code=themeColor, value=null, createTime=1777347456364, updateTime=1777347456364, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849512627724539, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989868900719, code=themeStyle, value=null, createTime=1777347456366, updateTime=1777347456366, creator=18614031015, updator=18614031015)]), Website(id=1255847989944398211, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1255847919539208197, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zhzyyxk/EN, language=EN, createTime=1777347093330, createBy=18614031015, updateTime=1777347417860, updateBy=18614031015, name=中华中医药学刊-英文, tplId=1146101810881728533, title=Chinese Archives of Traditional Chinese Medicine, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1255849538993119491, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989944398211, code=articleTextType, value=kx, createTime=1777347462652, updateTime=1777347462652, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849538972147968, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989944398211, code=banner, value=null, createTime=1777347462647, updateTime=1777347462647, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849539047645446, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989944398211, code=grayFlag, value=0, createTime=1777347462665, updateTime=1777347462665, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849538930204927, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989944398211, code=logo, value=https://castjournals.cast.org.cn/joweb/zhzyyxk/EN/file/pic?fileId=uitCA2DBwhJaQSiSV07uhw==, createTime=1777347462637, updateTime=1777347462637, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849539064422664, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989944398211, code=minRunFlag, value=0, createTime=1777347462669, updateTime=1777347462669, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849538988925186, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989944398211, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zhzyyxk/EN/file/pic, createTime=1777347462651, updateTime=1777347462651, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849539060228359, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989944398211, code=silenceFlag, value=0, createTime=1777347462668, updateTime=1777347462668, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849538980536577, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989944398211, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1777347462649, updateTime=1777347462649, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849539001508100, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989944398211, code=themeColor, value=null, createTime=1777347462654, updateTime=1777347462654, creator=18614031015, updator=18614031015), WebsiteProps(id=1255849539039256837, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1255847989944398211, code=themeStyle, value=null, createTime=1777347462663, updateTime=1777347462663, creator=18614031015, updator=18614031015)])], journalTitle=中华中医药学刊, weixinUrl=null, journalUrl=https://castjournals.cast.org.cn/zhzyyxk, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Archives of Traditional Chinese Medicine, journalPhotoCn=v4T+dd+NLAnioIpGAbkcEQ==, journalPhotoEn=RAy5vuC40hwJB+Y0pEARug==, journalFirstLetter=C, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false), detailUrlCn=https://castjournals.cast.org.cn/joweb/zhzyyxk/CN/10.13193/j.issn.1673-7717.2025.12.008, detailUrlEn=https://castjournals.cast.org.cn/joweb/zhzyyxk/EN/10.13193/j.issn.1673-7717.2025.12.008, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zhzyyxk/CN/PDF/10.13193/j.issn.1673-7717.2025.12.008, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zhzyyxk/EN/PDF/10.13193/j.issn.1673-7717.2025.12.008, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, reference=null)